Financials

  • Market Capitalization 194.7 M
  • Employee 49
  • Founded 2014
  • CEO N/A
  • Website www.korrobio.com
  • Headquarter Delaware, United States
  • FIGI BBG00GFMTC38
  • Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-0.64
Rapporto prezzo/fatturato
11.77

Related tickers

#NomePrezzo24h %7d %1M %1Y %Valore di MercatoUltimi 7 Giorni
3631
NERV
Minerva Neurosciences, Inc - Common Stock
4.27 USD-9.53%-13.21%-7.38%+142.61%198.93 M USD
3639
VYGR
Voyager Therapeutics, Inc. - Common Stock
3.24 USD-5.81%-11.48%-8.73%-30.32%195.76 M USD
3648
PLX
Protalix BioTherapeutics, Inc. Common Stock
2.40 USD-2.04%+4.35%+16.50%-17.81%193.37 M USD
3655
ARCT
Arcturus Therapeutics Holdings Inc. - Common Stock
6.71 USD-3.73%-8.58%-6.02%-50.04%190.72 M USD

Notizie